Wockhardt Limited
WOCKPHARMA
Pozycja w akcjach
#4493
Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical... Wockhardt Limited, together with its subsidiaries, operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally. It manufactures and trades pharmaceuticals, medicinal chemical, and botanical products, as well as chemicals and chemical products. The company also develops its flagship antibiotic, ZAYNICH zidebactam/cefepime, a novel beta lactam enhancer mechanism for the treatment of sepsis and hospital/ventilator associated pneumonia; FOVISCU, an antibiotic for gram-negative infections; MIQNAF nafithromycin, which targets azithromycin-resistant community respiratory pathogens; and ODRATE, a once-daily combination of ertapenem and zidebactam for resistant gram-negative infections through outpatient parenteral antimicrobial therapy. In addition, it develops and commercializes insulin analogs, glucagon-like peptide-1 agonists, and novel combination drug products; Biovac-B, a recombinant hepatitis-B vaccine; Wepox, a recombinant human erythropoietin; Wosulin, a recombinant human insulin; and Glaritus, a recombinant insulin glargine. Further, the company offers delivery devices for insulin, including Dispopen disposable pen and Mypen reusable pen. Wockhardt Limited was founded in 1967 and is headquartered in Mumbai, India.
Cena akcji
$21.04
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$3.42B
Zmiana (1 dzień)
-2.39%
Zmiana (1 rok)
38.07%
Kraj
IN
Handel Wockhardt Limited (WOCKPHARMA)
Kategoria
Healthcare
Historia stopy dywidendy dla Wockhardt Limited (WOCKPHARMA)
Stopa dywidendy (TTM) dla Wockhardt Limited (symbol akcji: WOCKPHARMA) na dzień 2024-03-31 wynosi: 0.00%
Średnia stopa dywidendy z ostatnich 5 lat: 0.01%
Średnia stopa dywidendy z ostatnich 5 lat: 0.01%
Historia stopy dywidendy dla Wockhardt Limited (WOCKPHARMA) od 2004 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | -100.00% |
| 2022 | 0.06% | 500.00% |
| 2021 | 0.01% | 0.00% |
| 2020 | 0.00% | 0.00% |
| 2019 | 0.00% | 0.00% |
| 2018 | 0.00% | -100.00% |
| 2017 | 1.60% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | 1.10% | -63.46% |
| 2014 | 3.01% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | -100.00% |
| 2010 | 0.01% | -99.60% |
| 2008 | 2.49% | -28.86% |
| 2007 | 3.50% | 136.49% |
| 2006 | 1.48% | 26.50% |
| 2005 | 1.17% | 60.27% |
| 2004 | 0.73% | 0.00% |
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 1.57% |
US
|
|
| 0.00% |
SE
|
|
| 0.00% |
FR
|
|
| 0.00% |
IT
|
|
| 2.29% |
HK
|
